AlphaCentric Advisors LLC Acquires New Stake in UnitedHealth Group Incorporated (NYSE:UNH)

AlphaCentric Advisors LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 7,123 shares of the healthcare conglomerate’s stock, valued at approximately $3,603,000. UnitedHealth Group accounts for 3.6% of AlphaCentric Advisors LLC’s portfolio, making the stock its 2nd largest holding.

A number of other large investors have also recently bought and sold shares of the business. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $37,000. Highline Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $55,000. Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $57,000. Finally, DecisionPoint Financial LLC grew its stake in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on UNH shares. Piper Sandler dropped their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Stephens raised their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Finally, Oppenheimer boosted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Down 1.4 %

Shares of UNH stock opened at $523.48 on Monday. The company’s fifty day simple moving average is $523.11 and its two-hundred day simple moving average is $563.09. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market capitalization of $481.75 billion, a price-to-earnings ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.